HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ash A Alizadeh Selected Research

Nucleotides

1/2020Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ash A Alizadeh Research Topics

Disease

61Neoplasms (Cancer)
01/2024 - 04/2005
20Lymphoma (Lymphomas)
12/2023 - 10/2009
12Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2024 - 04/2002
11Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2023 - 04/2003
9B-Cell Lymphoma (Lymphoma, B Cell)
03/2024 - 02/2011
7Residual Neoplasm
12/2023 - 10/2015
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 10/2015
6Lung Neoplasms (Lung Cancer)
01/2022 - 01/2017
4Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2023 - 09/2010
4Neoplasm Metastasis (Metastasis)
01/2020 - 04/2012
3Disease Progression
10/2020 - 09/2004
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2020 - 07/2012
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019 - 09/2004
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2010 - 05/2010
2Hodgkin Disease (Hodgkin's Disease)
01/2023 - 09/2012
2Leukemia
01/2023 - 05/2010
2Infections
01/2022 - 03/2012
2Sarcoma (Soft Tissue Sarcoma)
10/2021 - 12/2020
2Adenocarcinoma
01/2020 - 01/2019
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 01/2017
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2019 - 12/2010
2Melanoma (Melanoma, Malignant)
01/2019 - 07/2012
2T-Cell Lymphoma (Lymphoma, T Cell)
09/2012 - 03/2012
1cell-associated neurotoxicity
03/2024
1Cytokine Release Syndrome
03/2024
1Paraproteinemias (Monoclonal Gammopathy)
12/2023
1Brain Neoplasms (Brain Tumor)
01/2023
1COVID-19
03/2022
1Frailty
01/2022
1Glioma (Gliomas)
12/2020
1Esophageal Neoplasms (Esophageal Cancer)
01/2020
1Pain (Aches)
01/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020

Drug/Important Bio-Agent (IBA)

25Circulating Tumor DNAIBA
11/2023 - 05/2014
15DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2003
9Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2004
9Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2014
8Immunoglobulins (Immunoglobulin)IBA
12/2023 - 02/2013
7AntigensIBA
11/2023 - 01/2002
7Cell-Free Nucleic AcidsIBA
01/2023 - 11/2016
7Monoclonal AntibodiesIBA
01/2022 - 10/2009
5RNA (Ribonucleic Acid)IBA
12/2023 - 05/2015
5Rituximab (Mabthera)FDA Link
11/2023 - 09/2010
4Phosphotransferases (Kinase)IBA
11/2023 - 01/2013
3Chimeric Antigen ReceptorsIBA
04/2024 - 01/2023
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2024 - 11/2023
3Prednisone (Sone)FDA LinkGeneric
11/2023 - 06/2014
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023 - 06/2014
3Vincristine (Oncovin)FDA LinkGeneric
11/2023 - 06/2014
3B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
01/2017 - 07/2010
3Messenger RNA (mRNA)IBA
07/2012 - 07/2010
2Immunoglobulin M (IgM)IBA
12/2023 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2023 - 01/2023
2Etoposide (VP 16)FDA LinkGeneric
01/2023 - 11/2010
2cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2023 - 07/2014
2ChromatinIBA
01/2022 - 03/2015
2Immune Checkpoint InhibitorsIBA
10/2020 - 01/2019
2VaccinesIBA
01/2020 - 11/2019
2Peptides (Polypeptides)IBA
11/2019 - 01/2017
2Immunoglobulin Variable RegionIBA
01/2017 - 11/2012
2Interleukin-4 (Interleukin 4)IBA
07/2013 - 04/2005
2Interleukin-6 (Interleukin 6)IBA
07/2013 - 01/2004
2AntibodiesIBA
04/2012 - 09/2010
2Complementary DNA (cDNA)IBA
08/2003 - 04/2002
1Bispecific AntibodiesIBA
04/2024
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2024
1brexucabtagene autoleucelIBA
03/2024
1axicabtagene ciloleucelIBA
03/2024
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2024
1Toll-Like Receptor 9IBA
01/2024
1ibrutinibIBA
11/2023
1Nucleic AcidsIBA
01/2023
1pembrolizumabIBA
01/2023
1polatuzumab vedotinIBA
01/2023
1Complement System Proteins (Complement)IBA
11/2022
1Immunoglobulin G (IgG)IBA
03/2022
1Blocking AntibodiesIBA
03/2022
1Neutralizing AntibodiesIBA
03/2022
1Sphingosine-1-Phosphate ReceptorsIBA
01/2022
1BNT162 VaccineIBA
01/2022
1Ad26COVS1IBA
01/2022
12019-nCoV Vaccine mRNA-1273IBA
01/2022
1Interferon-gamma (Interferon, gamma)IBA
01/2022
1SphingosineIBA
01/2022
1AnthracyclinesIBA
01/2022
1Azacitidine (5 Azacytidine)FDA Link
01/2022
1GlutaminaseIBA
12/2020
1Flucytosine (Ancobon)FDA Link
12/2020
1vocimagene amiretrorepvecIBA
12/2020
1Hormones (Hormone)IBA
01/2020
1NucleotidesIBA
01/2020
1AndrogensIBA
01/2020

Therapy/Procedure

34Therapeutics
01/2023 - 10/2009
10Immunotherapy
04/2024 - 09/2012
7Drug Therapy (Chemotherapy)
01/2023 - 07/2010
4Radiotherapy
12/2020 - 10/2015
3Aftercare (After-Treatment)
01/2020 - 10/2015
2Precision Medicine
11/2022 - 07/2014
1VAP-cyclo protocol
01/2023
1Surgical Instruments (Clip)
01/2020